GIGABYTE-TECHNOLOGY
3.6.2024 11:31:29 CEST | Business Wire | Press release
Renowned globally for its research and development capabilities, GIGABYTE Technology will exhibit its products and solutions at COMPUTEX from June 4 to June 7 under the theme "ACCEVOLUTION," acclaiming the new era of accelerated-computing and time of AI. AI remains a major trend, attracting industry leaders, including the highest number of CEOs in COMPUTEX history. In celebration, Taipei 101 will be illuminated for COMPUTEX, with GIGABYTE lighting it up on June 4 from 6:30 PM to 10:00 PM, promoting the AI event and welcoming international guests.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240602653282/en/
Shining Bright atop Taipei 101, GIGABYTE Redefines AI Evolution Accelerated by Next-Generation Computing at COMPUTEX (Photo: Business Wire)
Prominent leaders in global chip development will attend COMPUTEX, aiming to assert their influence in the AI era and strengthen ties with the Taiwanese supply chain. GIGABYTE, an integral part of this industry, is honored to invite these CEOs to its booth to explore the latest technologies. GIGABYTE's diverse product lineup spans the entire AI lifecycle, featuring industry-leading technologies and flexible server solutions. These products, designed to meet future computing demands with advanced cooling solutions, will be showcased on an unprecedented scale at COMPUTEX. Additionally, GIGABYTE will present its Red Dot Award-winning PC products, new products demos, and AI experiences for gamers and creators.
GIGABYTE has consistently been the fastest to market with the most diverse range of AI servers. This year, the G593 flagship AI server series, known for its high-density features and flexible design, is displayed to support NVIDIA's next-gen chips H200 and B100, as well as models designed for AMD's MI300X. The showcase will also feature the new X series servers, based on NVIDIA's MGX modular design, which shortens development times and accelerates data center deployment. Customers can choose between AMD EPYC, Intel Xeon x86 CPUs, or NVIDIA Grace Hopper Arm superchips, offering tailored configurations for specific computational needs.
Large Language Models (LLM) have become increasingly popular in AI. To handle the growing number of parameters, GIGABYTE is showcasing servers supporting NVIDIA's latest Blackwell architecture, featuring the highly acclaimed high-density designs with the powerful B100 and B200 superchips. The B100 will be compatible with the G593 series hardware, while the B200's next-level performance introduces thermal challenges beyond the capacity of traditional air cooling. GIGABYTE has addressed this with its industry-leading thermal engineering by employing direct liquid cooling. The highly anticipated GB200 will also be demonstrated in a liquid-cooled cabinet as the GB200 NVL72, acting as a massive GPU that can achieve 30 times the inference performance of an equivalent number of H100 GPUs. This allows visitors not only to witness these innovations firsthand but also to engage in discussions about the future of AI development and computing deployment.
Introducing GIGA POD, GIGABYTE’s one-stop rack integration solution leveraging its 20+ years of server proficiency and experience gained from CSP partnerships. GIGA POD is a complete system integration including architecture planning, equipment integration, software installation, and post-deployment testing. It offers different configurations of AI servers with NVIDIA SXM or AMD Instinct GPUs or NVIDIA Superchips and is gradually expanding to future top-tier GPU-equipped AI servers. GIGA POD is also a prime demonstration of GIGABYTE’s thermal engineering, fitting an HGX module in a 5U chassis of an air-cooled G593 server. Such dense server enables customers the option to choose either a 9-rack configuration with 4 AI servers per 42U rack or a 5-rack configuration with 8 AI servers per 48U rack, achieving nearly double the utilization space and greatly improving resource efficiency. GIGABYTE has also invited Northern Data Group, a key client of its cluster computing solution (GIGA POD) and Europe’s largest generative AI cloud service provider, to participate in a special event "Executive Dialogue with AI Visionaries" with the General Manager of GIGABYTE's subsidiary, Giga Computing. The live conversation will cover the collaboration, keys to success, and perspectives on the future of AI.
AI development extends beyond GPU computations to comprehensive data center infrastructure, including storage and network transmission. GIGABYTE's R&D expertise in thermal, mechanical, and modular design ensures a diverse product range across IT architectures. At COMPUTEX, GIGABYTE will showcase servers for cloud and edge computing, high-performance, and high-density storage. Additionally, general-purpose servers for SMBs and DIY server motherboards for micro-enterprises and individuals will be displayed, supporting AI development at all scales.
GIGABYTE has pioneered advanced cooling solutions, mastering technologies like direct liquid and immersion cooling. With expertise in cross-disciplinary integration, GIGABYTE has developed its own cold plates, DLC racks, and immersion tanks, offering comprehensive cooling solutions. At COMPUTEX, GIGABYTE will showcase single-phase immersion cooling, direct liquid cooling, and a new rear-door heat exchanger (RDHx) cooling rack. Collaborating with nVent, GIGABYTE deployed Spain's third-ranked supercomputer, Hyperion, using full-rack servers with RDHx. This setup, connected to an outdoor chiller, delivers up to 54,000 watts of heat dissipation per hour, reducing air conditioning needs and effectively managing computational hotspots.
GIGABYTE presents both robust AI model training capabilities and practical AI applications through industrial-grade embedded computers. Demonstrations span smart factories with AI-enabled machine vision and high-stability embedded computers for remote control, as well as retail bars utilizing panel PCs combined with AI recognition and big data analysis. Advancements in AI and next-generation CPU/GPU also bolster smart automotive applications, enhancing ADAS and in-vehicle Telematics devices.
The rise of AI is transforming personal computing. GIGABYTE's Z790 series motherboards are designed for different scenarios, and support RTX 40 SUPER series graphics cards, deliver peak performance with enhanced core counts, VRAM, and memory speeds. Utilizing AI acceleration, the graphics cards offer exceptional computing and graphics processing for both professional tasks and AAA gaming, while preparing users for new AI-driven applications. The AORUS 17X and 16X AI laptops feature GIGABYTE's AI Nexus with AI Boost, AI Generator, and AI Power Gear, providing improved performance, seamless AI generation, and extended battery life. At our booth's AI experience area, visitors can explore the latest AI applications and real-time interactions, including NVIDIA ACE and ChatRTX, delving immersively into cutting-edge AI technologies.
Visit GIGABYTE’s COMPUTEX event page.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240602653282/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
